123I Scan with Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry before 131I Treatment of Metastatic Thyroid Cancer

Jolanta M. Durski, Carrie B. Hruska, Trond V. Bogsrud, Mabel Ryder, Geoffrey B. Johnson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '123I Scan with Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry before 131I Treatment of Metastatic Thyroid Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences